Latest news with #MarkWells
Cision Canada
3 days ago
- Business
- Cision Canada
Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
World's leading* contact lens brand ACUVUE brings pioneering innovation for astigmatic patients with presbyopia, providing visual clarity and comfort 1 Launch reinforces Johnson & Johnson's position as world leader in contact lenses* – pushing boundaries in optical and material science JACKSONVILLE, Fla., June 23, 2025 /CNW/ -- Today, Johnson & Johnson, † a global leader in eye health, announced the launch of ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, the first and only daily disposable contact lens for people with both astigmatism and presbyopia. 2 This pioneering contact lens provides patients crisp, clear, stable vision at all distances and in all lighting conditions, along with comfort that lasts all day. 1 The lens is now available in the U.S. and Canada, and the launch of ACUVUE OASYS MAX 1-Day for ASTIGMATISM is expected later this summer. Experience the full interactive Multichannel News Release here: "Building on our legacy of firsts, we are thrilled to launch ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM," said Peter Menziuso, Company Group Chairman, Vision at Johnson & Johnson. ‡"ACUVUE is the world's leading contact lens brand* and with these new products, we now have the first and only complete family of daily-disposable contact lenses. # 2 Clear sight empowers people to live their best lives, and we believe everyone should have the opportunity to achieve it. That's why we focus our innovation on areas with the greatest unmet needs for patients. Today, we are working to fulfill that promise, providing millions of patients with a differentiated ACUVUE experience." "Finally, patients with both presbyopia and astigmatism can enjoy the freedom and comfort of a daily disposable lens without compromising the quality of their vision," said Dr. Mark Wells, "This new lens was designed to help patients who struggle with multiple vision correction issues, allowing them to experience the comfort and clarity of MAX." 1 Based on extensive studies, 95% of people wearing ACUVUE OASYS MAX 1-DAY MULTIFOCAL for ASTIGMATISM contact lenses reported their vision was clear during their daily activities, § 1 while 87% saw clearly while driving at night. § 1 Additionally, 92% of wearers said their eyes felt comfortable throughout the entire day. ¶ 1 Astigmatism affects about 50% of the population, 3 making it one of the most common vision conditions. It is characterized by imperfections in the curvature of the eye, leading to distorted or blurred vision. Presbyopia, commonly beginning in the early to mid-40s, is the gradual loss of near vision. Traditionally, there has been a gap for people with astigmatism when they begin to experience presbyopia. They've had to make compromises by either switching from daily contact lenses to reusables, or layering reading glasses over their contact lenses. The ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM contact lens is built with the combination of four proprietary technologies 4 which enable its comfort and visual results: BLINK STABILIZED Design helps the lens stay put, so vision is not distorted or blurry when you blink or move your head. 1,4 PUPIL OPTIMIZED Design helps meet presbyopic vision needs, even as you age and your vision continues to change. 5 TearStable Technology helps keep the lens hydrated, facilitating end of day comfort. †† 1,6,7,8 Finally, the OptiBlue Light Filter provides 60% blue-violet light filtering, the highest in the industry.** ‡‡ 7,8 Later this summer, the ACUVUE OASYS MAX 1-Day for ASTIGMATISM contact lens will launch in both the U.S. and Canada, making the ACUVUE OASYS MAX 1-Day Family of lenses the first and only complete daily disposable family of contact lenses on the market. # 2 Both ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM and ACUVUE OASYS MAX 1-Day for ASTIGMATISM are planned to be introduced in additional markets outside North America during 2025 and beyond. To learn more about ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM or to search for an eye care provider, visit † About Vision at Johnson & Johnson Johnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients' eyes. We have a bold ambition: Vision Made Possible – improving sight for more than 40 million people each year. Through cutting-edge innovation, expertise in material and optical science, and advanced technologies, we are revolutionizing the way people see and experience the world. Visit us at follow @JNJVision on Twitter, Johnson & Johnson | Vision on LinkedIn, and @JNJVision on Facebook. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more about our MedTech sector's global scale and deep expertise in cardiovascular, orthopaedics, surgery and vision solutions at Follow us at @JNJMedTech and on LinkedIn. Johnson & Johnson Vision Care, Inc., a Johnson & Johnson Company. * Source Euromonitor International Limited; Eyewear 2025 edition; value sales at rsp, all retail channels, 2023 data; "ACUVUE ® family of brands" represents aggregated sales of the following brands: 1-day ACUVUE ®, ACUVUE ® OASYS, ACUVUE ® VITA ®, and ACUVUE ® 2. ‡ Peter Menziuso is an employee of Johnson & Johnson # Full/complete family consists of sphere, multifocal, toric, and multifocal toric contact lenses § Model-adjusted percent estimate ¶ T3B descriptive summaries: n=171 **Filtering of HEV light by contact lenses has not been demonstrated to confer any health benefit to the user, including but not limited to retinal protection, protection from cataract progression, reduced eye strain, improved contrast, improved acuity, reduced glare, improved low light vision, or improved circadian rhythm/sleep cycle. The Eye Care Professional should be consulted for more information. †† Versus ACUVUE ® OASYS 1-Day, Dailies Total1 ®, My Day ®, Infuse™ and Precision 1 ®. ‡‡ Versus publicly available information for standard daily use contact lenses as of December 2023. © Johnson & Johnson and its affiliates 2025 2025PP10152 1 JJV Data on file, 2024: Subjective Standalone Claims for ACUVUE® OASYS MAX 1-Day MULTIFOCAL Contact Lenses for ASTIGMATISM 2 JJV Data on File 2025, World's First and Only Daily Disposable Multifocal Toric Contact Lens 3 Young G, Sulley A & Hunt C. Prevalence of Astigmatism in Relation to Soft Contact Lens Fitting; Eye & CL, 2011: 37: 20-25 4 JJV Data on File: Technical Description of ACUVUE ® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM 5 JJV Data on File 2020. ACUVUE OASYS MULTIFOCAL Fit and Performance Claims 6 JJV Data on File 2022. Effect on Tear Film and Evaluation of Visual Artifacts with ACUVUE ® OASYS MAX 1-Day Family. 7 JJV Data on File 2022. JJV Data on File 2022 TearStable™ Technology Definition. 8 JJV Data on File 2022. Material Properties: 1-DAY ACUVUE ® MOIST, 1-DAY ACUVUE ® TruEye ®, ACUVUE ® OASYS 1-Day with HydraLuxe ® Technology and ACUVUE ® OASYS MAX 1-Day with TearStable™ Technology Brand Contact Lenses and other daily disposable contact lens brands. Important information for contact lens wearers: ACUVUE Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, remove the lens and contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional, call 1-800-843-2020, or download the Patient Instruction Guides. Cautions Concerning Forward-Looking Statements This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding the launch of ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM and ACUVUE OASYS MAX 1-Day for ASTIGMATISM contact lenses. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new products and patents attained by competitors; manufacturing difficulties and delays; product efficacy or safety concerns resulting in product recalls or regulatory action; changes to applicable laws and regulations, including global health care reforms; changes in behavior and spending patterns of purchasers of health care products and services; and trends toward health care cost containment. A further list and descriptions of these risks, uncertainties and other factors can be found in Johnson & Johnson's most recent Annual Report on Form 10-K, including in the sections captioned "Cautionary Note Regarding Forward-Looking Statements" and "Item 1A. Risk Factors," and in Johnson & Johnson's subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission. Copies of these filings are available online at or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments Kristyna Muñoz [email protected] Investor Contact: Sandra Easton [email protected]
Yahoo
28-01-2025
- Business
- Yahoo
Downtown Portland saw ‘encouraging' increase in foot traffic, employee presence in 2024: Report
PORTLAND, Ore. (KOIN) – Downtown Portland saw an increase in foot traffic and worker presence in 2024 — marking an 'encouraging sign' in the city's appeal and resilience post-pandemic, according to a new report from Downtown Portland Clean & Safe. Since 2009, Downtown Portland Clean & Safe has been tracking foot traffic as part of the organization's mission to encourage vitality of the city's core. According to the latest foot traffic report, released January 21, Downtown Portland is continuing to see 'strong signs of recovery.' Oregon one of the worst states for retirement, WalletHub says Overall, foot traffic saw a 3% increase in 2024 compared to 2023, along with a post-pandemic high of more than 2.4 million visitors in five separate months, the report says. Additionally, foot traffic has increased by 54% compared to downtown's pandemic low in 2021. Downtown Portland Clean & Safe credits the rise in foot traffic, in part, to the return of major events in the city — including the Rockstar Energy Open, which brought thousands of people to Tom McCall Waterfront Park, and concerts at Providence Park — notably, the show, which brought 30,000 attendees downtown, according to the report. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now In addition to those events, the report also credits improvements in other key areas that led to increased foot traffic. This includes employee presence, which has risen by 8% in 2024 compared to 2023, the report states, noting Tuesdays, Wednesdays, and Thursdays are 'the most favored days' for employees to be in the district. Additionally, the report highlights the opening of nearly 40 retail businesses and a recovery in tourism bringing more foot traffic to the city's core. An earthquake rattled the Cascadia fault 325 years ago. Here's what we know about the massive quake According to the report, tourism's 'strong recovery,' was especially seen in June and July when demand for downtown Portland rooms grew by more than 10%. In August, room demand increased by more than 17%, with that trend continuing into the fall. 'The return of iconic events like Project Pabst and new attractions like the Rockstar Energy Open and Coraline's Curious Cat Trail, combined with consistent growth in worker traffic and visitor numbers, shows that Portland is reclaiming its status as a premier destination for both culture and commerce,' said Andrew Hoan, president and CEO of the Portland Business Alliance and the Portland Metro Chamber. 'We're seeing a revitalized downtown that's attracting both local workers and tourists, creating an increasingly dynamic city center.' Mark Wells, the executive director of Downtown Portland's Clean & Safe added, 'Downtown Portland continues to show encouraging signs of recovery, with five months reaching the significant milestone of 2.4 million visitors in 2024,' noting, 'The steady increase in overall foot traffic, and particularly the notable uptick in worker presence downtown, demonstrates that our recovery continues to move in the right direction.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
28-01-2025
- Health
- Yahoo
Doctors surgery to be taken back by health board
A GP management company that was criticised by patients, doctors and Wales' first minister is handing back the keys to one of its doctors surgeries in Wales. Safety, staffing and supply concerns at surgeries managed by Leicestershire-based eHarley Street were revealed by BBC Wales at the end of last year - prompting criticism from Eluned Morgan. Now Aneurin Bevan University Health Board has said it will take over running of Brynmawr Medical Practice from the beginning of March. eHarley Street have been asked to comment. Aneurin Bevan University Health Board said it was focusing on "working closely" with surgery staff and the local community. Inquiry demand for GPs where patients feel 'unsafe' Angry doctors owed thousands refuse to work FM attacks GP firm allegedly not paying staff Dr Mark Wells, clinical lead at Brynmawr Medical Practice in Blaenau Gwent said, "this is fantastic news for Brynmawr", but added he was not sure about any other practices. He said he believed it would take six months for the surgery to "stabilise", but that staff are "delighted". Earlier this month, Ms Morgan said she was "deeply concerned" about claims that doctors had been unpaid and that patients were unable to get appointments at surgeries managed by the company. In November BBC Wales revealed locum doctors were refusing to work at Welsh surgeries managed by eHarley Street, because of claims they were owed around £250,000 in unpaid wages. Doctors also warned of "dangerous" staffing levels and "potentially catastrophic" supply shortages at practices supported by the GP management company. All of the claims were denied by eHarley Street, who at the time said it did "not hold any contracts for General Medical Services (GMS) in Wales". Aneurin Bevan University Health Board also denied holding any contracts with the company. Welsh surgeries managed by eHarley Street: Brynmawr Medical Practice Blaenavon Medical Practice Pontypool Medical Centre Bryntirion Surgery, Bargoed Tredegar Health Centre Aberbeeg Medical Practice Gelligaer Surgery, Hengoed Lliswerry Medical Centre, Newport The Corporation Road Surgery, Cardiff. Now, BBC Wales understands eHarley Street will pull out of managing Brynmawr Medical Practice from 1 March, following a meeting between staff, company representatives and Aneurin Bevan health board. But doctors have told BBC Wales there has been no "direct contact or reassurance" that money still owed to locum GPs will be paid. Dr Samantha Jenkins, who was owed more than £10,000 after working at Blaenavon Medical Practice, in Torfaen, and Brynmawr Medical Practice said, "we have all been left high and dry". She said: "There has been no correspondence from the health board to affected locum doctors throughout all of this". Aneurin Bevan health board has been asked to comment. Previously eHarley Street said there was a plan to pay outstanding wages to doctors. Senedd Member Alun Davies has asked the Senedd's health committee to investigate how eHarley Street became involved in managing doctors surgeries in Wales. He said he intends to ask the auditor general for Wales to investigate the use of any public funds. In December there were demands for an inquiry into eHarley Street after patients, some with terminal illnesses, said they were having difficulty accessing appointments and treatments. "It frightens me - I don't feel safe," said Katrina Hughes, 69, a terminal cancer patient who struggled to get an appointment or see the same doctor at Brynmawr Medical Practice in Blaenau Gwent. "There's no continuity of care at all," she said. She was among around 100 people who attended a public meeting to discuss services at the practice - many said they struggled to get appointments or were waiting for medication and test results. Doctors said they were taking legal action to recover their unpaid wages. In January several Senedd Members criticised the service being provided by eHarley Street-managed surgeries in Wales. In a previous statement the partners who run eHarley Street and the surgeries it manages said they faced "significant financial constraints" but were "committed to addressing these challenges". A spokesman for Aneurin Bevan health board said it had received eHarley Street's resignation at Brynmawr, with "an official transfer date" set for 1 March. "Our focus now is on working closely with the staff at Brynmawr Medical Practice and the local community to provide good access to quality primary care services within the area," the spokesman added. "The GP partnership remains in enhanced monitoring for their other practices within the Health Board and we will continue to work closely with them to ensure primary care services are sustainable and meet the needs of our patients."
